USPTO serial 79444628
YOUTH IS YOUR FUTURE BBHC
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- VAGHANI, MAYUR C
- Law office
- TMO LAW OFFICE 124
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with YOUTH IS YOUR FUTURE BBHC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Development of cell therapy products; drug discovery services; research and development of pharmaceutical preparations for treating malignant tumours; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the area of cancerous diseases; drug development; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the field of pharmaceuticals; laboratory research in the field of pharmaceuticals; providing medical research information in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; research relating to pharmaceuticals; pharmaceutical product evaluation; conducting clinical testing of medicines; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; toxicity testing for research purposes; research and development services in the field of nutritional supplements; circular RNA vaccine research; research of induced pluripotent stem cells; research in the field of genetic diseases; development of gene-based medicines; gene therapy research; providing medical research information in the field of genetics; medical laboratory services; scientific research services for medical purposes; scientific investigations for medical purposes; research and development of technology for medicinal chemical manufacturing; research and development services in the field of medical preparations; medical research laboratory services for predicting disease; medicine research; analysis and evaluation of medical product development; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; pharmaceutical evaluation services; medical and pharmacological research services; consulting services in the fields of medical laboratory testing; analysis of peptide for medical research purposes; biopsy for medical research; blood testing for medical research; blood collection for medical research; analysis of human serum for medical research; analysis of human tissues for medical research; scientific research in the fields of medicine/health and pharmacology; industrial research in the fields of medicine/health and pharmacology; research and consultancy therefor in the fields of medicine/surgery and specimen analysis; research in the fields of medicine/surgery and specimen analysis; engineer services in the medical technology; medical research services; research in the field of interventional radiology; clinical surgery research; conducting clinical trials for others [scientific research]; evaluating of clinical trial progress; conducting clinical trials; scientific research in the field of epidemiology; stem cell research services; dental research laboratory services; conducting clinical trials in the field of acupuncture therapy; laboratory research services relating to dermatology. | ACTIVE | — |
| 044 | Medical examination of individuals; provision of reports relating to the medical examination of individuals; medical analysis services relating to the treatment of persons; residential medical advice services; residential medical treatment services; advisory services relating to health; providing information in the fields of health and wellness; health risk assessment surveys; health advice and information services; health assessment surveys; health assessment services; health screening agency services; health screening; consultancy services relating to health care; advisory services relating to health care; health care in the nature of health maintenance organizations; preparation of reports relating to health care matters; managed health care services; healthcare; consulting services relating to health care; professional consultancy relating to health care; information services relating to health care; health counseling; professional consultancy relating to health; providing health information; physical examination services; health clinic services; providing health care information via a global computer network; medical services in the field of treatment of chronic pain; personal therapeutic services relating to hair regrowth; hair restoration; laboratory analysis services relating to the treatment of persons; cosmetic surgery services; plastic and cosmetic surgery services; plastic surgery services; injectable filler treatments for cosmetic purposes; personal therapeutic services relating to cellulite removal; cellulite treatment services; surgical treatment services; rehabilitation of alcohol addicted patients; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; health care services for treating cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; drug testing for substance abuse; drug use screening services; rehabilitation for substance abuse patients; healthcare services relating to fitness; hair restoration services for medical purposes; behavioral analysis for medical purposes; DNA screening for medical purposes; health care consultancy services [medical]; health farm services [medical]; health clinic services [medical]; immunodetection services for medical purposes; medical and surgical diagnostic services; preparation of reports relating to medical matters; medical skincare services; scar treatment; medical treatment using cultured cells; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; analysis of human tissues for medical treatment; providing information about fat stem cells for medical purposes; services of a human cell bank; cultured cell bank services for medical transplantation; medical services relating to the removal, treatment and processing of human cells; stem cell storage; stem cell bank services; medical services relating to the removal, treatment and processing of stem cells. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 4, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 4, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 16, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |